3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
22
Neoplasms
20
Lung Neoplasms
10
Colorectal Neoplasms
8
Uterine Cervical Neoplasms
6
Papillomavirus Infections
5
Head and Neck Neoplasms
5
Fatigue
5
Multiple Myeloma
4
Lymphoma
4
Hematologic Neoplasms
4
Urinary Bladder Neoplasms
3
Skin Neoplasms
3
Prostatic Neoplasms
3
Melanoma
3
Hematopoietic and Lymphoid System Neoplasm
3
Gastrointestinal Neoplasms
3
Sleep Wake Disorders
2
Skin Cancer Prevention
2
Obesity
2
Neoplasm Metastasis
2
Motor Activity
2
Leukemia, Myeloid, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Hematopoietic and Lymphatic System Neoplasm
2
Diabetes Mellitus
2
Depression
2
Caregiver
2
Cancer Survivor
2
Interventions
Paclitaxel
4
Carboplatin
4
Pemetrexed
2
Palliative Care
2
Gemcitabine
2
temsirolimus
1
rucaparib
1
pembrolizumab
1
niraparib
1
nintedanib
1
nilotinib
1
liposomal doxorubicin
1
fosaprepitant
1
atezolizumab
1
argatroban
1
Topotecan
1
Thrombopoietin
1
Palonosetron
1
Ocoxin
1
Laparoscopy
1
Heparin, Low-Molecular-Weight
1
Filgrastim
1
Electrocardiography
1
Educational Status
1
Dexamethasone
1
Darbepoetin alfa
1
Cognitive Behavioral Therapy
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Genital Neoplasms, Female
×
Educational Status
×
Clear all
NCT04679675
2023-09-18
STEP
Kaiser Permanente
Phase NA
Completed
32,771 enrolled
11 charts